C57BL/6JCya-Usp2em1flox/Cya
Common Name
Usp2-flox
Product ID
S-CKO-11600
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-53376-Usp2-B6J-VA
When using this mouse strain in a publication, please cite “Usp2-flox Mouse (Catalog S-CKO-11600) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Usp2-flox
Strain ID
CKOCMP-53376-Usp2-B6J-VA
Gene Name
Product ID
S-CKO-11600
Gene Alias
B930035K21Rik, Ubp41
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 9
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000034508
NCBI RefSeq
NM_198092
Target Region
Exon 3~4
Size of Effective Region
~2.1 kb
Overview of Gene Research
Usp2, or ubiquitin-specific processing protease 2, is a multifunctional deubiquitinating enzyme. It modulates cell cycle progression, carcinogenesis, and energy metabolism. It is involved in pathways such as the regulation of cyclins, Aurora-A, p53 signaling, and the CLOCK/BMAL1 complex-related rhythmic gene expression [2].
Usp2 knockout mice exhibit changes in locomotion and male fertility, suggesting its roles in the central nervous system and male genital tract [2].
In cancer, depletion of Usp2 causes endoplasmic reticulum-associated degradation of PD-L1, enhancing antitumor immunity by increasing CD8+ T cells infiltration and reducing immunosuppressive cell infiltration [1]. Also, targeting the Usp2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression [3]. Inhibition of Usp2 can enhance TRAIL-mediated cancer cell death through downregulation of survivin [5]. Moreover, Usp2 inhibition can prevent infection with ACE2-dependent coronaviruses in vitro and protect against SARS-CoV-2 in mice [4].
In conclusion, Usp2 is a crucial deubiquitinating enzyme with diverse functions. Its study using knockout mouse models has revealed its significance in cancer immunotherapy, autophagy regulation in cancer, and protection against ACE2-dependent coronavirus infections. These findings provide potential therapeutic targets for related diseases.
References:
1. Kuang, Zean, Liu, Xiaojia, Zhang, Na, Song, Danqing, Deng, Hongbin. 2023. USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. In Cell death and differentiation, 30, 2249-2264. doi:10.1038/s41418-023-01219-9. https://pubmed.ncbi.nlm.nih.gov/37670038/
2. Kitamura, Hiroshi, Hashimoto, Mayuko. 2021. USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes. In International journal of molecular sciences, 22, . doi:10.3390/ijms22031209. https://pubmed.ncbi.nlm.nih.gov/33530560/
3. Xiao, Wenjing, Wang, Jianqun, Wang, Xiaojing, Tong, Qiangsong, Zheng, Liduan. 2022. Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. In Autophagy, 18, 2615-2635. doi:10.1080/15548627.2022.2044651. https://pubmed.ncbi.nlm.nih.gov/35253629/
4. Dang, Fabin, Bai, Lei, Dong, Jiazhen, Lan, Ke, Wei, Wenyi. 2023. USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice. In Science translational medicine, 15, eadh7668. doi:10.1126/scitranslmed.adh7668. https://pubmed.ncbi.nlm.nih.gov/38055802/
5. Lee, Tak Gyeom, Woo, Seon Min, Seo, Seung Un, Chang, Young-Chae, Kwon, Taeg Kyu. 2023. Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin. In International journal of molecular sciences, 24, . doi:10.3390/ijms241612816. https://pubmed.ncbi.nlm.nih.gov/37628997/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
